These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27399327)

  • 1. Percutaneous CT-guided Radiofrequency Ablation for Lymph Node Oligometastases from Hepatocellular Carcinoma: A Propensity Score-matching Analysis.
    Pan T; Xie QK; Lv N; Li XS; Mu LW; Wu PH; Zhao M
    Radiology; 2017 Jan; 282(1):259-270. PubMed ID: 27399327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results.
    Mu L; Sun L; Pan T; Lyu N; Li S; Li X; Wang J; Xie Q; Deng H; Zheng L; Peng J; Shen L; Fan W; Wu P; Zhao M
    Int J Hyperthermia; 2018 Feb; 34(1):59-67. PubMed ID: 28540809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.
    Fukuda H; Numata K; Moriya S; Shimoyama Y; Ishii T; Nozaki A; Kondo M; Morimoto M; Maeda S; Sakamaki K; Morita S; Tanaka K
    Radiology; 2014 Aug; 272(2):598-604. PubMed ID: 24689883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.
    Takuma Y; Takabatake H; Morimoto Y; Toshikuni N; Kayahara T; Makino Y; Yamamoto H
    Radiology; 2013 Dec; 269(3):927-37. PubMed ID: 24086071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
    Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
    Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
    Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
    Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and technical feasibility of percutaneous ablation for lymph node metastases of hepatocellular carcinoma.
    Yuan Z; Xing A; Zheng J; Li W
    Int J Hyperthermia; 2019 Jan; 36(1):160-168. PubMed ID: 30776925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial.
    Zhang YJ; Liang HH; Chen MS; Guo RP; Li JQ; Zheng Y; Zhang YQ; Lau WY
    Radiology; 2007 Aug; 244(2):599-607. PubMed ID: 17641378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
    Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
    Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
    Zhao M; Wang JP; Pan CC; Li W; Huang ZL; Zhang L; Fang WJ; Jiang Y; Li XS; Wu PH
    Eur J Radiol; 2012 Oct; 81(10):2717-25. PubMed ID: 22245655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of percutaneous radiofrequency ablation and CyberKnife(®) for initial solitary hepatocellular carcinoma: A pilot study.
    Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kishimoto Y; Okubo Y; Makino H; Tsukamoto N; Igarashi Y; Sumino Y
    World J Gastroenterol; 2015 Dec; 21(48):13490-9. PubMed ID: 26730160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
    Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
    Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
    Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
    Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
    Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
    World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up.
    Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
    Clin Radiol; 2013 Dec; 68(12):e641-51. PubMed ID: 23973161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography.
    Rhim H; Choi D; Kim YS; Lim HK; Choe BK
    Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
    Kim HJ; Park BK; Park JJ; Kim CK
    Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.